Abstract
Ethnic differences in the risk of severe COVID-19 may be linked to household composition. We quantified the association between household composition and risk of severe COVID-19 by ethnicity for older individuals. With the approval of NHS England, we analysed ethnic differences in the association between household composition and severe COVID-19 in people aged 67 or over in England. We defined households by number of generations living together, and used multivariable Cox regression stratified by location and wave of the pandemic and accounted for age, sex, comorbidities, smoking, obesity, housing density and deprivation. We included 2 692 223 people over 67 years in wave 1 (01/02/2020-31/08/2020) and 2 731 427 in wave 2 (01/09/2020-31/01/2021). Multigenerational living was associated with increased risk of severe COVID-19 for White and South Asian older people in both waves (e.g. wave 2, 67+ living with 3 other generations vs 67+ year olds only: White HR 1·61 95% CI 1·38-1·87, South Asian HR 1·76 95% CI 1·48-2·10), with a trend for increased risks of severe COVID-19 with increasing generations in wave 2. Multigenerational living was associated with severe COVID-19 in older adults. Older South Asian people are over-represented within multigenerational households in England, especially in the most deprived settings. The number of generations in a household, number of occupants, ethnicity and deprivation status are important considerations in the continued roll-out of COVID-19 vaccination and targeting of interventions for future pandemics.
Funding This research was funded in part, by the Wellcome Trust. For the purpose of open access, the author has applied a CC-BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://github.com/opensafely/hh-classification-research/tree/master/docs
Funding Statement
The OpenSAFELY data science platform is funded by the Wellcome Trust. BGs work on clinical informatics is supported by the NIHR Oxford Biomedical Research Centre and the NIHR Applied Research Collaboration Oxford and Thames Valley. BGs work on better use of data in healthcare more broadly is currently funded in part by: (1) the Wellcome Trust NIHR (2) Oxford Biomedical Research Centre (3) NIHR Applied Research Collaboration Oxford and Thames Valley (4) the Mohn-Westlake Foundation. All DataLab staff are supported by BGs grants on this work. RM holds a Sir Henry Wellcome fellowship. AS is employed by LSHTM on a fellowship sponsored by GSK. HF holds a UKRI fellowship. KB holds a Wellcome Senior Research Fellowship (220283/Z/20/Z). EW holds grants from MRC. EH holds a fellowship from NIHR. NG is a full-time employee of Aetion, Inc AYSW holds a fellowship from BHF. BMK is also employed by NHS England working on medicines policy and clinical lead for primary care medicines data. IJD holds grants from NIHR and GSK. RME is funded by (1) HDR UK (2) the MRC and (3) the HPRU in Modelling and Economics.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted by the Health Research Authority (Research Ethics Committee) reference 20/LO/0651) and by the LSHTM Ethics Board (reference 21863)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data were linked stored and analysed securely within the OpenSAFELY-TPP platform: https://opensafely.org/. Data include pseudonymised data such as coded diagnoses medications and physiological parameters. No free text data are included. All code is shared openly for review and re-use under MIT open license [https://github.com/opensafely/hh-classification-research]. Detailed pseudonymised patient data is potentially re-identifiable and therefore not shared.